Nitroglycerin and Skin injury - a phase IV clinical study of FDA data

Summary:

Skin injury is found among people who take Nitroglycerin, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Nitroglycerin and have Skin injury. It is created by eHealthMe based on reports of 41,819 people who have side effects when taking Nitroglycerin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

41,819 people reported to have side effects when taking Nitroglycerin.
Among them, 7 people (0.02%) have Skin injury.


What is Nitroglycerin?

Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 42,060 Nitroglycerin users for its effectiveness, alternative drugs and more.

What is Skin injury?

Skin injury is found to be associated with 686 drugs and 358 conditions by eHealthMe.

Number of Nitroglycerin and Skin injury reports submitted per year:

Could Nitroglycerin cause Skin injury?

Gender of people who have Skin injury when taking Nitroglycerin *:

  • female: 42.86 %
  • male: 57.14 %

Age of people who have Skin injury when taking Nitroglycerin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 33.33 %
  • 60+: 66.67 %

Common drugs people take besides Nitroglycerin *:

  1. Lasix: 3 people, 42.86%
  2. Vesicare: 3 people, 42.86%
  3. Zocor: 3 people, 42.86%
  4. Zoloft: 2 people, 28.57%
  5. Primidone: 2 people, 28.57%
  6. Eliquis: 2 people, 28.57%
  7. Forteo: 2 people, 28.57%
  8. Spiriva: 2 people, 28.57%
  9. Topamax: 2 people, 28.57%
  10. Hydroxyzine: 2 people, 28.57%

Common side effects people have besides Skin injury *:

  1. Weakness: 3 people, 42.86%
  2. Fall: 3 people, 42.86%
  3. Nausea And Vomiting: 3 people, 42.86%
  4. Injection Site Erythema (redness at injection site): 2 people, 28.57%
  5. Rashes (redness): 2 people, 28.57%
  6. Back Injury: 2 people, 28.57%
  7. Dizziness: 2 people, 28.57%
  8. Feeling Abnormal: 2 people, 28.57%
  9. Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin): 2 people, 28.57%
  10. Head Injury: 2 people, 28.57%

Common conditions people have *:

  1. Osteoporosis (bones weak and more likely to break): 2 people, 28.57%
  2. Carcinoid Tumor: 2 people, 28.57%
  3. Immunodeficiency Common Variable: 1 person, 14.29%
  4. Heart Attack: 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Nitroglycerin and have Skin injury?

Check whether Skin injury is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Nitroglycerin:

Skin injury treatments and more:

COVID vaccines that are related to Skin injury:

How severe was Skin injury and when was it recovered:

Expand to all the drugs that have ingredients of nitroglycerin:

Common drugs associated with Skin injury:

All the drugs that are associated with Skin injury:

Common conditions associated with Skin injury:

All the conditions that are associated with Skin injury:

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin (the active ingredients of Nitroglycerin) and Nitroglycerin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: